PhaseBio Pharmaceuticals OverviewPhaseBio Pharmaceuticals Net Income
Profitability analysis for PHAS.
Quarterly Net Income
-$16.78M
↑ 41.49% YoY
As of Jun 2022
Annual Net Income (TTM)
$27.84M
↑ 124.95% YoY
Trailing 12 months ending Jun 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...